Influencers promoting ‘overwhelmingly’ misleading information about medical tests on social media
Peer-Reviewed Publication
Updates every hour. Last Updated: 11-Jul-2025 23:11 ET (12-Jul-2025 03:11 GMT/UTC)
Swelling caused by brain cancer is a serious problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.
Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a novel series of orally available covalent CDK12/13 dual inhibitors, as a potential option against refractory and treatment-resistant cancers. Published in the Journal of Medicinal Chemistry (IF=7.2), the study showcases the discovery of compound 12b, a potent, selective, and safe therapy targeting CDK12/13, empowered by Insilico’s proprietary generative AI platforms including PandaOmics and Chemistry42.